{"id":"W3082639272","doi":"10.1016/j.ejca.2020.07.028","title":"Increased risk of immune checkpoint inhibitor–induced type 1 diabetes mellitus with the new approved 6-week scheme of pembrolizumab in patients with melanoma?","year":2020,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Merck Sharp and Dohme; Bristol-Myers Squibb Canada; Medac; Les Laboratories Pierre Fabre; Novartis; Bristol-Myers Squibb; Novartis Pharma; Roche; Amgen","keywords":"Pembrolizumab; Medicine; Type 1 diabetes; Internal medicine; Melanoma; Diabetes mellitus; Adjuvant; Oncology; Gastroenterology; Cancer; Immunotherapy; Endocrinology; Cancer research","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006079438,0.0001919469,0.0003417546,0.000224702,0.0002387148,0.0006975543,0.0002757209,0.0006835939,0.002446064],"category_scores_gemma":[0.001683314,0.0001798458,0.000754388,0.0005825959,0.0001498144,0.0005893377,0.0001875099,0.001186314,0.0002285429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002663542,"about_ca_system_score_gemma":0.0003072602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001220461,"about_ca_topic_score_gemma":0.001829629,"domain_scores_codex":[0.9995766,0.0001354653,0.00003288187,0.0001039192,0.00008121076,0.0000697896],"domain_scores_gemma":[0.9992465,0.0001258812,0.0003764442,0.00006487477,0.00004433038,0.0001420493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003565019,0.0002378599,0.9760321,0.00004576787,0.00034354,0.00032521,0.00002828181,0.0000724265,0.0008331347,0.0001117681,0.0005397602,0.01786504],"study_design_scores_gemma":[0.0001854373,0.0009231562,0.9943975,0.00003606139,0.0004596517,0.001211665,0.0001321311,0.0005755984,0.0002276569,0.00023465,0.001604918,0.00001152249],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925485,0.003608799,0.0002550608,0.0009309948,0.0001327161,0.00001233275,0.0002109101,0.000008661715,0.002292032],"genre_scores_gemma":[0.9979246,0.0008194697,0.0002377342,0.0002811208,0.000118538,0.000007007251,0.0002039232,0.000003143822,0.0004045012],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002446064,"threshold_uncertainty_score":0.008182883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0122356714177343,"score_gpt":0.2187317812198983,"score_spread":0.206496109802164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}